Theoharides T C, Kops S K, Bondy P K, Askenase P W
Biochem Pharmacol. 1985 May 1;34(9):1389-98. doi: 10.1016/0006-2952(85)90675-6.
Pretreatment of mast cells with various psychotropic agents was shown to permit preferential release of serotonin without substantial release of histamine or massive degranulation. Differential release involved both endogenous, granule-stored serotonin, and exogenous radiolabeled serotonin that had been taken up by the cell. This phenomenon occurred in mast cells stimulated to secrete with suboptimal concentrations of the classic mast cell secretagogue compound 48/80, was associated with drugs of several different structures and known mechanisms of action, and could be inhibited by certain prostaglandins. Furthermore, differential release of serotonin occurred in mast cells of retired breeders without the use of drugs or other exogenous agents. Light microscopic studies of mast cells undergoing differential release showed minimal degranulation, indicating that most of the serotonin release did not occur via classic exocytosis. The ability of mast cell to selectively release serotonin, by a mechanism unlike that occurring in allergic anaphylactic secretion, constitutes one of the first instances of differential release from secretory cells, suggests a new mechanism of release of secretory products, and expands the potential role of mast cells in the pathophysiology of the body.
用各种精神药物对肥大细胞进行预处理,结果显示可优先释放5-羟色胺,而组胺不会大量释放,也不会发生大量脱颗粒。差异释放涉及内源性、颗粒储存的5-羟色胺以及细胞摄取的外源性放射性标记5-羟色胺。这种现象发生在用次优浓度的经典肥大细胞促分泌剂化合物48/80刺激分泌的肥大细胞中,与几种不同结构和已知作用机制的药物有关,并且可被某些前列腺素抑制。此外,在老龄种畜的肥大细胞中,不使用药物或其他外源性试剂也会发生5-羟色胺的差异释放。对经历差异释放的肥大细胞进行的光学显微镜研究显示脱颗粒极少,这表明大多数5-羟色胺释放并非通过经典的胞吐作用发生。肥大细胞通过一种不同于变应性过敏分泌中发生的机制选择性释放5-羟色胺的能力,构成了分泌细胞差异释放的首批实例之一,提示了分泌产物释放的一种新机制,并扩展了肥大细胞在机体病理生理学中的潜在作用。